Efficacy of NNC109-0012 in Subjects With Active Rheumatoid Arthritis

NCT01282255 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation
Rheumatoid Arthritis

Interventions

DRUG: NNC109-0012
DRUG: placebo

Sponsor

Novo Nordisk A/S